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Background and purpose: The Na+/Ca2+ exchanger (NCX) may contribute to triggered activity and transmural dispersion of
repolarization, which are substrates of torsades de pointes (TdP) type arrhythmias. This study examined the effects of selective
inhibition of the NCX by SEA0400 on the occurrence of dofetilide-induced TdP.
Experimental approach: Effects of SEA0400 (1 mmol·L-1) on dofetilide-induced TdP was studied in isolated, Langendorff-
perfused, atrioventricular (AV)-blocked rabbit hearts. To verify the relevance of the model, lidocaine (30 mmol·L-1) and
verapamil (750 nmol·L-1) were also tested against dofetilide-induced TdP.
Key results: Acute AV block caused a chaotic idioventricular rhythm and strikingly increased beat-to-beat variability of the RR
and QT intervals. SEA0400 exaggerated the dofetilide-induced increase in the heart rate-corrected QT interval (QTc) and did
not reduce the incidence of dofetilide-induced TdP [100% in the SEA0400 + dofetilide group vs. 75% in the dofetilide
(100 nmol·L-1) control]. In the second set of experiments, verapamil further increased the dofetilide-induced QTc prolongation
and neither verapamil nor lidocaine reduced the dofetilide-induced increase in the beat-to-beat variability of the QT interval.
However, lidocaine decreased and verapamil prevented the development of dofetilide-induced TdP as compared with the
dofetilide control (TdP incidence: 13%, 0% and 88% respectively).
Conclusions and implications: Na+/Ca2+ exchanger does not contribute to dofetilide-induced TdP, whereas Na+ and Ca2+
channel activity is involved in TdP genesis in isolated, AV-blocked rabbit hearts. Neither QTc prolongation nor an increase in
the beat-to-beat variability of the QT interval is a sufficient prerequisite of TdP genesis in rabbit hearts.
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Introduction
Torsades de pointes (TdP) is a life-threatening form of poly-
morphic ventricular tachycardia, which can be evoked by
several cardiac or non-cardiac drugs that disturb the process
of repolarization of the myocytes. According to the most
widely accepted theory, the mechanism of TdP initiation
(trigger) involves an early (EAD) or delayed (DAD)
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afterdepolarization-induced ectopic beat, while the mecha-
nism of the arrhythmia maintenance (substrate) involves
re-entry circuits produced by an increase in spatial dis-
persion of the repolarization of the ventricular wall
(Antzelevitch and Oliva, 2006). Dofetilide, an inhibitor of
the rapid component of the delayed rectifier potassium
current (IKr), prolongs repolarization, induces EAD, increases
dispersion of repolarization and can evoke TdP (Belardinelli
et al., 2003).
The Na+/Ca2+ exchanger (NCX) is considered to play an
important role in Ca2+ handling of cardiac myocytes. In
forward mode, the NCX extrudes Ca2+ from the cell and brings
Na+ into the cytosol with a ratio of 1 : 3 respectively; in
reverse mode, it operates in the opposite direction (Bers,
2001). This exchange of three positive charges for two posi-
tive charges makes the exchanger electrogenic and this may
cause substantial depolarization in forward mode, leading to
EAD- and DAD-induced triggered activity (extrasystoles)
(Sipido et al., 2007). Selective inhibition of the NCX by
SEA0400 reduced the amplitude of both dofetilide-induced
EADs and the strophanthidin-induced DADs in isolated
canine ventricular papillary and Purkinje fibres (Nagy et al.,
2004). This implies that NCX activity may play a role in the
generation of the trigger of drug-induced TdP.
The intrinsic transmural dispersion of repolarization is
amplified by any compound that reduces net repolarizing
currents, such as dofetilide, by preferential prolongation of
the repolarization of the midmyocardial cells (M) cells, which
provide the substrate for circus movement re-entrant arrhyth-
mias (Belardinelli et al., 2003). The NCX may contribute to
the prolonged action potential of the canine M cells, which
produces transmural electrical heterogeneity and re-entry cir-
cuits (Zygmunt et al., 2000). This implies that NCX activity
may play a role in the generation or the maintenance mecha-
nism of TdP.
To date, the role of NCX in the genesis of TdP has not been
examined. As earlier investigations implied that the NCX may
contribute to the genesis of drug-induced TdP, the present
study examined the anti-arrhythmic effect of the inhibition of
the NCX by a selective NCX inhibitor, SEA0400, on the occur-
rence of dofetilide-induced TdP in isolated, Langendorff-
perfused, atrioventricular (AV) nodal-ablated rabbit hearts.
The in vitro, isolated, AV-ablated rabbit heart model is fre-
quently used for testing the proarrhythmic liability of drugs
(Thomsen et al., 2006). Interestingly, the ability of pharmaco-
logical intervention to reduce the incidence of TdP induced
by K+ channel blocking drugs has not been examined in this
model. Our results show that NCX inhibition with SEA0400
did not reduce the incidence of dofetilide-induced TdP. As this
result questions either the role of NCX in TdP or the validity
of this model, we conducted a second series of experiments
aimed at validating the model with drugs known to alleviate
TdP in other experimental models and in man. Thus, the
anti-arrhythmic effect of the inhibition of the inward L-type
Ca2+ current (ICaL) by verapamil and the inhibition of the
inward Na+ current (INa) by lidocaine was tested against
dofetilide-induced TdP in isolated, Langendorff-perfused,
AV-ablated rabbit hearts. Also, an attempt was made to deter-
mine whether the occurrence of dofetilide-induced TdP was
related to the prolongation of the heart rate-corrected QT
(QTc) interval or the beat-to-beat variability of the QT interval
in the applied model.
Methods
Animals and general methods
Animals were handled in accordance with the European Com-
munity guidelines for the use of experimental animals, and
the protocol was reviewed and approved by the Ethical Com-
mittee for the Protection of Animals in Research at the Uni-
versity of Szeged, Hungary.
Female New Zealand white rabbits weighing 2.5  0.24 kg
were used for the experiments. The animals were anticoagu-
lated with sodium heparin (1000 IU) injected into the mar-
ginal ear vein and stunned by a blow to the neck. The heart
was rapidly removed via thoracotomy and rinsed in ice-cold
modified Krebs–Henseleit buffer solution containing (in
mmol·L-1): NaCl 118.5, CaCl2 1.8, glucose 11.1, MgSO4 0.5,
NaH2PO4 1.2, NaHCO3 25 and KCl 3. A K+ concentration of
3 mmol·L-1 was chosen, as the proarrhythmic action of
dofetilide tended to be exacerbated by perfusion with
3 mmol·L-1 K+ versus 4 mmol·L-1 K+ in isolated, AV-blocked
rabbit hearts (Barrett et al., 2001). The aorta was cannulated
and the heart placed in a Langendorff apparatus and hearts
were retrogradely perfused with the modified Krebs–Henseleit
buffer solution at a constant temperature of 37°C as described
above. A mixture of 95% O2 and 5% CO2 was bubbled through
the buffer, which was equilibrated to pH 7.4. All solutions
were filtered (5 mm pore size filter) before use. The perfusion
pressure was maintained constant at 70 mm Hg. Volume con-
ducted electrocardiogram (ECG) was recorded by using
National Instruments data acquisition hardware (PC card,
National Instruments, Austin, TX, USA) and SPEL Advanced
Haemosys software (version 2.76, Experimetria Ltd. and
Logirex Software Laboratory, Budapest, Hungary). Coronary
flow was measured with a glass flowmeter (Cole-Parmer
Instrument Company, Vernon Hills, IL, USA) positioned
immediately above the retrogradely perfused aorta and was
later corrected for the weight of each heart to give values in
mL·min-1·g-1. An incision was made in the right atrium and
the AV node was ablated using forceps 2 min after mounting
the heart. AV ablation was regarded successful when the P
wave was dissociated from the QRS complex on real-time ECG
recording. After AV ablation, the hearts were allowed to beat
in their own spontaneous rhythm. As a single ventricular
pacing stimulus can initiate TdP in the presence of a Class III
antiarrhythmic drug (e.g. E-4031) in isolated, AV-blocked
rabbit hearts (Asano et al., 1997), ventricular pacing was not
applied in the present experiments in order to avoid the
occurrence of electrical pacing-induced arrhythmias. Hearts
were equilibrated for 15 min before starting the experimental
protocol. At the end of each experiment, the atria were
removed from the heart and the ventricles were weighed.
Experimental protocol
In the first set of experiments, four groups (n = 8 hearts in
each group) [dofetilide 100 nmol·L-1 (DOF1), SEA0400
1.0 mmol·L-1 + dofetilide 100 nmol·L-1 (SEA + DOF), and
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control groups distilled water (H2O) and dimethyl sulphoxide
(DMSO), solvent of dofetilide and SEA0400 (DMSO)] were
compared. A H2O control group was used as DMSO may affect
the repolarization (Pinney et al., 1995; Himmel, 2007). The
administration of the NCX inhibitor SEA0400 or the solvent
of the SEA0400 was started at the beginning of a 20 min
‘pretreatment’ period, after 15 min of initial perfusion with
modified Krebs–Henseleit solution. Dofetilide was added to
the perfusion solution at the beginning of a 30 min ‘treat-
ment’ period. In the H2O and the DMSO control groups, the
hearts were perfused with the equivalent volume of the
solvent water or DMSO throughout the whole experiment
(Table 1). The concentration of SEA0400 (1 mmol·L-1) was
chosen in order to achieve maximal NCX inhibition without
significantly affecting any other ion current (Tanaka et al.,
2002; Birinyi et al., 2005; Acsai et al., 2007; Farkas et al., 2008).
As SEA0400 administration did not decrease the incidence of
dofetilide-induced TdP ventricular tachycardia, a second set of
experiments was designed to examine whether it is possible to
reduce dofetilide-induced TdP with other drugs in this model.
Lidocaine and verapamil were chosen as test drugs as both can
successfully reduce the incidence of drug-induced TdP in other
experimental models (Carlsson et al., 1993; Milberg et al.,
2005). The second set of experiments comprised three groups
of hearts: (i) 100 nmol·L-1 dofetilide (DOF2), (ii) 30 mmol·L-1
lidocaine + 100 nmol·L-1 dofetilide (LID + DOF); and (iii)
750 nmol·L-1 verapamil + 100 nmol·L-1 dofetilide (VER + DOF).
Each group contained n = 8 hearts. The administration of
lidocaine or verapamil or the solvent DMSO was started at the
beginning of the ‘pretreatment’ period, whereas dofetilide was
added to the perfusion solution at the beginning of the ‘treat-
ment’ period (Table 1). In either set of experiments, the admin-
istration of the drug or the solvent was time-matched (Table 1),
and the choice of drug solution was made by reference to a
randomization table. Randomization was achieved by coding
each group with a letter whose meaning was unknown to the
operator. Unbiased analysis was achieved by using stock solu-
tions prepared by a second operator, who did not participate in
the heart perfusion or data analysis.
Coronary flow measurement and ECG analysis
Coronary flow and ECG intervals were measured at predeter-
mined time points. Coronary flow values were read directly
from the flowmeter every 5 min during the experiment and
1 min before and after switching to a different perfusion solu-
tion and normalized to heart weight. After completion of the
experiments, the data were replayed and the QT and RR
intervals were measured by manual positioning of on-screen
markers. The QT interval was defined as the time between the
first deviation from the isoelectric line of QRS complex until
the end of the TU wave. In the rabbit hearts, where the T or U
wave overlapped the following QRS complex of the subse-
quent ventricular beat, the extrapolation method was used to
measure the length of the QT (or QU) interval (Farkas et al.,
2004).
As QT interval is influenced by the heart rate, baseline data
for ventricular heart rates and QT intervals were used to
determine the relationship between the RR interval and the
QT interval in sinus rhythm before AV ablation and in idio-
ventricular escape rhythm after AV ablation according to
Batey and Coker (2002) and Farkas and Curtis (2003). These
data were obtained from 56 isolated, Langendorff-perfused
rabbit hearts prepared as described above and used here in the
present study. Forty consecutive QT intervals were measured
together with the corresponding RR intervals in each hearts
immediately before and 10 min after the mechanical AV abla-
tion. Simple linear regression revealed a positive correlation
between QT and RR intervals in sinus rhythm (QTSinus =
0.326RR + 103.4) as well as in idioventricular escape rhythm
(QTAV-block = 0.081RR + 186.8), although the regression coeffi-
cient (R) and the slope of the regression line were greater
during sinus rhythm as compared with the values calculated
in idioventricular escape rhythm (Figure 1A,B). As there was a
difference between the slope of the regression line of the sinus
and the idioventricular rhythm, a QT correction was calcu-
lated for either rhythm in a manner similar to that described
by Batey and Coker (2002). The equations were rearranged to
allow the calculation of the rate-corrected QT interval in sinus
rhythm (QTc-Sinus) at an RR interval of 300 ms (i.e. a ven-
tricular rate of 200 beats·min-1) using the formula QTc-Sinus =
QTSinus - 0.326(RR-300) and in idioventricular escape rhythm
(QTc-AV) at an RR interval of 500 ms (i.e. a ventricular rate of
120 beats·min-1) using the formula QTc-AV = QTAV-block -
0.081(RR-500). With these equations, plotting QTc-Sinus and
QTc-AV against the corresponding RR interval produces a
regression line with a slope of zero (Figure 1C,D), indicating
that these corrections remove the influence of heart rate. As
Table 1 The experimental protocol applied in isolated, Langendorff-perfused, AV-blocked rabbit hearts
Group n Pretreatment (20 min) Treatment (30 min)
First set of experiments
H2O 8 H2O H2O
DMSO 8 DMSO DMSO
Dofetilide 100 nmol·L-1 8 DMSO DMSO + dofetilide
SEA0400 1.0 mmol·L-1 + dofetilide 100 nmol·L-1 8 DMSO + SEA0400 DMSO + SEA0400 + dofetilide
Second set of experiments
Dofetilide 100 nmol·L-1 8 DMSO DMSO + dofetilide
Lidocaine 30 mmol·L-1 + dofetilide 100 nmol·L-1 8 DMSO + lidocaine DMSO + lidocaine + dofetilide
Verapamil 750 nmol·L-1 + dofetilide 100 nmol·L-1 8 DMSO + verapamil DMSO + verapamil + dofetilide
The groups of hearts, the periods of the experiments and the applied drugs are summarized. In the baseline period of the experiments, all hearts were perfused
with Krebs buffer; the perfusion solution was then switched to the test drug in the second period of the experiment (pretreatment); in the last period dofetilide
was added to the perfusion (treatment). Group size is indicated by n.
AV, atrioventricular; DMSO, dimethyl sulphoxide.
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we examined drug effects after AV ablation in idioventricular
escape rhythm, all QTc intervals in this study were corrected
according to the QTc-AV.
From the ECG, the incidence and the time to onset of TdP
arrhythmias were obtained. TdP was defined as a polymorphic
ventricular tachycardia with runs of four or more ventricular
premature beats, where clear twisting of the QRS complexes
around the isoelectric axis could be seen in at least one ECG
lead.
Measurement of the beat-to-beat variability of the QT intervals
and the RR intervals
The beat-to-beat variability of the QT and the RR intervals
was determined from the manual measurement data on 40
consecutive QT intervals and the corresponding RR intervals
at predetermined time points, that is, in the last minute
before AV ablation, in the last minute of drug-free state after
AV ablation, in the last minute of the ‘pretreatment’ period
before switching to the dofetilide perfusion and in the fifth
minute of the dofetilide infusion or before the onset of TdP.
A computer program was developed in a .NET environment
to obtain the following parameters of the beat-to-beat
variability of the QT and RR intervals: for a sequence of RR
or QT interval durations, the ‘root mean square’ (RMS)











, where di represents the sequence of RR or
QT interval durations and N is the total number of intervals.
Another approach for characterizing the beat-to-beat vari-
ability of RR and QT intervals is to take their successive
differences (Ddj = dj+1 - dj; 0  j  N - 2, where dj represents
the RR or QT interval durations and N is the total number of
intervals) and calculate the RMS of these differences:
RMSSD = [ ]( )E dΔ 2 , where E denotes the mean value. The
percentage of successive QT intervals that differ by more
than 8 ms (PNN8), the ‘instability’ of the RR and QT inter-
vals, the ‘short-term variability’ and the ‘long-term variabil-
ity’ of the RR and QT intervals were calculated as described
earlier (Vincze et al., 2008).
Figure 1 Correlation between individual values of the QT and RR intervals in sinus rhythm (A) and after AV ablation (B) in isolated
Langendorff-perfused rabbit hearts. Correlation between individual values of the ‘rate-corrected’ QT intervals and the RR intervals in sinus
rhythm (C) and after AV ablation (D) in isolated Langendorff-perfused rabbit hearts. All panels contain 2240 baseline data points obtained from
56 isolated rabbit hearts. QTc-Sinus, the heart rate-corrected QT interval during sinus rhythm; QTc-AV, the ventricular heart rate-corrected QT
interval after AV nodal ablation. AV, atrioventricular; QTc, heart rate-corrected QT interval.
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Exclusion criteria
Any heart with a coronary flow <3 mL·min-1·g-1 or asystole
longer than 20 s during the whole experimental protocol was
excluded. Longer than 20 s asystole was found after the start
of dofetilide perfusion in six hearts pretreated with verapamil
and in three hearts pretreated with lidocaine, these hearts
were excluded. Additional experiments were performed in
order to maintain equal group sizes.
Solutions
Perfusion solutions were prepared fresh each day. Dofetilide
and SEA0400 were dissolved in DMSO. All final test solutions
for heart perfusion contained 0.08 mL DMSO in 1 L of modi-
fied Krebs–Henseleit solution. Likewise, the DMSO control
solution contained 0.08 mL DMSO in 1 L of modified Krebs–
Henseleit solution. The H2O control solution contained
0.08 mL water in 1 L of modified Krebs–Henseleit solution. In
the second set of experiments, lidocaine and verapamil were
dissolved in water, and all final test solution for heart perfu-
sion contained 0.1 mL water in 1 L of modified Krebs–
Henseleit solution.
Statistics
Continuous data were expressed as mean  standard error of
the mean (SEM). All data from independent samples, except
the incidences of TdP, were compared with Kruskal–Wallis
tests. Within-group comparisons of the variability parameters
were performed by Wilcoxon tests. The incidences of TdP
were compared by using Fisher’s exact probability test with
the Bonferoni correction, that is, the P values of Fisher’s exact
probability test were multiplied by 4 in the first set of experi-
ments or 2 in the second set of experiments (the numbers of
comparisons) to allow multiple comparisons (Altman, 1991).
P < 0.05 was taken as indicative of a statistically significant
difference between values.
Drugs and materials
CaCl2, DMSO, lidocaine and verapamil were purchased
from Sigma-Aldrich, Inc., St. Louis, MO, USA. All other salts
were purchased from Molar Chemical Ltd., Budapest,
Hungary. The dofetilide was a generous gift from Gedeon
Richter Ltd. (Budapest, Hungary). The synthesis of 2-[
4-[(2,5-difluorophenyl)methoxy]phenoxy]-5-ethoxy-aniline
(SEA0400) was performed by Ferenc Fülöp (Department of
Pharmaceutical Chemistry, University of Szeged, Szeged,
Hungary) according to a method described earlier (Farkas
et al., 2008). Water for the preparation of perfusion solution
was obtained from a reverse osmosis system (Milli-Q RG,
Millipore Ltd., Billerca, MA, USA) fed by distilled water, and
had a specific resistivity of >18 MW.
Results
The effect of AV block on the ventricular rhythm and
repolarization
As expected, the applied mechanical AV block decreased the
average ventricular heart rate (Figure 2). Interestingly, AV
ablation also led to a chaotic and irregular spontaneous ven-
tricular rhythm (Figure 2B), and it strikingly increased all
parameters of the beat-to-beat variability of the RR intervals
(Figure 2D). The measurement of the RR variability param-
eters over a longer period (over 3 min) provided results similar
to those of the measurement of the RR variability parameters
over a shorter (40-consecutive-beat-long) period (data not
shown). In addition, the AV ablation increased all QT vari-
ability parameters, which reflected a tentative beat-to-beat
repolarization (Figure 2C).
TdP incidences and onset times
In the first set of experiments, TdP occurred in the majority of
the dofetilide-perfused hearts (Figure 3A). NCX inhibition
with SEA0400 did not reduce the incidence of dofetilide-
induced TdP (Figure 3B) and did not affect the onset time of
this arrhythmia (325  30 s and 409  97 s after switching to
dofetilide perfusion in the DOF1 and SEA + DOF group respec-
tively). Interestingly, TdP occurred in one heart in the DMSO-
perfused control group 1174 s after switching to DMSO
perfusion from Krebs solution.
In the second set of experiments, dofetilide provoked TdP
in the majority of the hearts as seen in the first set of experi-
ments. Lidocaine significantly decreased the incidence of
dofetilide-induced TdP, while verapamil completely pre-
vented the development of this arrhythmia (Figure 3C).
The RR and the QTc intervals and the beat-to-beat variability of
the RR and QT intervals
Pretreatment period In the first set of experiments, neither
DMSO nor SEA0400 affected the mean RR interval, the mean
QTc interval (Figure 4A,C) or any of the QT or RR variability
parameters (Tables 2 and 3). After the exclusion of all hearts
that experienced asystole longer than 20 s from the second set
of experiments (see exclusion criteria in Methods) the mean
RR interval, the mean QTc interval (Figure 5A,C) or any of the
QT or RR variability parameters (Tables 2 and 3) did not sig-
nificantly differ between the lidocaine, verapamil and the
control groups before dofetilide perfusion.
Treatment period In the first set of experiments, dofetilide per-
fusion significantly increased the mean QTc intervals
(Figure 4B) and the beat-to-beat variability of the QT interval
(Table 2) without affecting the mean RR interval (Figure 4D)
and the beat-to-beat variability of the RR interval (Table 3).
NCX inhibition with SEA0400 exaggerated the dofetilide-
induced increase in the mean QTc interval (Figure 4B) and
further increased some of the QT variability parameters
(Table 2). Further, SEA0400 upon dofetilide perfusion
increased the beat-to-beat variability of the RR interval
(Table 3) without affecting the mean RR interval (Figure 4D).
In the second set of experiments, verapamil further
increased the dofetilide-induced QTc prolongation whereas
lidocaine did not affect the mean QTc interval significantly
when compared with that of the DOF2 group (Figure 5B).
Verapamil tended to increase the beat-to-beat variability of
the QT interval but only the QT RMS parameter reached
statistical significance. Similarly, lidocaine added to dofetilide
perfusion significantly elevated QT RMS as compared with
that of the DOF2 group (Table 2).
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Verapamil added to dofetilide perfusion significantly
increased the mean RR interval, that is, decreased the ven-
tricular heart rate as compared with that of the DOF2 group
(Figure 5D). Verapamil and lidocaine tended to increase the
beat-to-beat variability of the RR interval but only the RR RMS
parameter of the VER + DOF group reached statistical signifi-
cance as compared with the DOF2 group (Table 3).
Coronary flow
In the first set of experiments, group mean baseline coronary
flows 1 min before the ‘pretreatment’ period ranged from 7.0
 0.5 to 11.2  0.4 mL·min-1·g-1 (no significant difference
between the groups). There was a small time-dependent fall
(range 6–16%) in flow in all groups, which is typical of the
model. As the treatment groups were time-matched, this did
not influence the interpretation of the results. There was no
significant difference between the various groups at any time
point of the experiments (data not shown).
In the second set of experiments, group mean baseline
coronary flows 1 min before the ‘pretreatment’ period ranged
from 7.9  0.5 to 10.4  0.5 mL·min-1·g-1 (no significant
difference between the groups). Perfusion with verapamil sig-
nificantly increased the coronary flow as compared with the
DOF2 group (the maximum coronary flow values were 13.3 
1.3 and 6.7  0.2 mL·min-1·g-1 in the VER + DOF and the
DOF2 group respectively). Lidocaine did not influence the
coronary flow as compared with the DOF2 group (data not
shown).
Discussion
The present study is the first to examine the role of NCX in
the genesis of drug-induced TdP ventricular tachycardia.
Selective inhibition of NCX by SEA0400 neither decreased the
incidence of dofetilide-induced TdP nor influenced the onset
time of this arrhythmia in isolated, Langendorff-perfused,
AV-ablated rabbit hearts. On the other hand, SEA0400 signifi-
cantly prolonged the mean QTc interval in the presence of
dofetilide. The inhibition of the Na+ channels by lidocaine as
well as the block of the L-type Ca2+ channels by verapamil
Figure 2 Representative ECG recordings during sinus rhythm (A) and after AV ablation (B). Beat-to-beat variability parameters of the QT (C)
and the RR (D) intervals during sinus rhythm and after AV ablation. Vertical arrows indicate P waves. All values shown as means  SEM. *P <
0.05 versus sinus rhythm. ECG I-III, electrocardiographic leads similar to standard limb leads I, II and III; sinus, sinus rhythm; AV, atrioventricular;
AV block, chaotic idioventricular escape rhythm after AV ablation; mean, the mean of the measured 40 consecutive QT or RR intervals (ms);
min, the minimum of the measured 40 consecutive QT or RR intervals (ms); max, the maximum of the measured 40 consecutive QT or RR
intervals (ms); SD, the standard deviation of the measured 40 consecutive QT or RR intervals (ms); RMSSD, the root mean square of the
successive difference of the QT or RR intervals (ms); instability, QT or RR instability (ms); LTV, long-term variability of the QT or RR intervals (ms);
STV, short-term variability of the QT or RR intervals (ms).
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significantly antagonized the genesis of dofetilide-induced
TdP. However, verapamil further increased the dofetilide-
induced QTc prolongation and neither verapamil nor
lidocaine reduced the dofetilide-induced increase in the beat-
to-beat variability of the QT interval.
Selective and effective inhibition of NCX in the isolated rabbit
heart: no effect on TdP
SEA0400 is probably the most effective inhibitor of the NCX
(Matsuda et al., 2001), with an inhibitory potency 10- to 100-
fold higher than that of KB-R7943 (Takahashi et al., 2003). In
isolated rabbit myocardial cells, SEA0400 equally suppressed
the inward and the outward NCX current (INa/Ca), IC50 values
of the inward (forward) and the outward (reverse) currents
were 243 and 309 nmol·L-1 respectively (Farkas et al., 2008).
SEA0400 at a concentration of 1.0 mmol·L-1 inhibits 70–80%
of the NCX function (Matsuda et al., 2001; Tanaka et al., 2002;
Birinyi et al., 2005; Farkas et al., 2008). SEA0400 is also con-
sidered to be the most selective NCX inhibitor, as it is con-
sidered to be selective for the NCX up to a concentration of
1.0 mmol·L-1 without markedly influencing any other ion
transport mechanisms (Tanaka et al., 2002; Nagy et al., 2004).
In a recent study, which was performed with the same
Langendorff perfusion preparation that we used in the present
study, SEA0400 at a concentration of 1.0 mmol·L-1 increased
significantly the left ventricular contractility in isolated rat
hearts, whereas the drug (0.1–1.0 mmol·L-1) exerted only an
insignificant, but concentration-dependent positive inotropic
effect in isolated rabbit hearts (Farkas et al., 2008). Likewise,
Szentandrássy et al. found that 0.3 and 1.0 mmol·L-1 SEA0400
increased the developed pressure and the amplitude of the
Ca2+ transient in isolated, Langendorff-perfused rat hearts
(Szentandrássy et al., 2008). These earlier results suggest indi-
rectly that SEA0400 at a concentration of 1.0 mmol·L-1 effec-
tively blocks the NCX in isolated hearts. The effectiveness of
verapamil and lidocaine against dofetilide-induced TdP vali-
dates our model, as it responded to intervention known to
reduce the incidence of drug-induced TdP. This observation
suggests that effective inhibition of NCX by SEA0400 did not
exert an anti-arrhythmic effect against dofetilide-induced TdP
because NCX does not play a role in the genesis of TdP in
isolated, AV-blocked rabbit hearts.
NCX does not provide the trigger for TdP
According to the most widely accepted theory, TdP is initiated
by an EAD-induced ectopic beat (Antzelevitch and Oliva,
2006). EAD is generated in phase 2 or 3 of the prolonged
repolarization as a result of increased depolarizing currents
such as ICaL and INa, but also inward NCX current (Sipido et al.,
2006). Stimulation of the b-adrenoceptors increases ICaL and
may result in an overload of the Ca2+ stores of the sarcoplas-
mic reticulum (SR), and a subsequent spontaneous SR Ca2+
release can appear as an early Ca2+ aftertransient (Sipido et al.,
2006). This activates the forward mode of the NCX leading to
EAD generation in guinea pig, canine and human myocytes
(Tweedie et al., 1997; Volders et al., 1997). This effect can be
evoked with isoprenaline and suppressed by a non-selective
NCX blocker Ni2+ (Volders et al., 1997). It was also observed
that the Class III antiarrhythmic clofilium and d,l-sotalol pro-
longed repolarization, but evoked EADs only in the presence
of adrenaline, which could be suppressed by reducing inward
NCX in canine Purkinje fibre and epicardial myocytes (Patter-
son et al., 1997). While these results emphasize the role of
sympathetic stimulation, NCX-generated EAD as a result of
intracellular Ca2+ overload is not always restricted to sympa-
thetic activity. Inward NCX current can generate EAD even in
the absence of b- adrenoceptor-stimulated, spontaneous SR
Ca2+ release when K+ currents are decreased or inhibited
(Volders et al., 2000). Accordingly, the selective inhibition of
NCX with SEA0400 effectively decreased the amplitude of
EADs evoked by the co-perfusion of BaCl2 and dofetilide in
canine ventricular papillary muscles and Purkinje fibres (Nagy
et al., 2004). Moreover, acceleration of the pacing rate or a
single premature beat could induce EAD activity and prolon-
gation of action potential duration (APD) in canine ventricu-
lar M cell preparations pretreated with the IKr blocker E4031
via a mechanism linked to an intracellular calcium-loading-
induced electrogenic NCX current (Burashnikov and Antz-
elevitch, 1998).
Some authors claim that DAD-induced triggered activity
(similarly to EAD) can also initiate TdP (Antzelevitch and
Figure 3 Dofetilide-induced torsades de pointes (TdP) ventricular
tachycardia (A). Incidence of TdP in the first set of experiments (B)
and in the second set of experiments (C). The hearts were perfused
with distilled water (H2O), solvent of dofetilide and SEA0400
(DMSO), 100 nmol·L-1 dofetilide (DOF1) or 1.0 mmol·L-1 SEA0400
and 100 nmol·L-1 dofetilide (SEA + DOF) in the first set of experi-
ments. Hearts were perfused with 100 nmol·L-1 dofetilide (DOF2),
30 mmol·L-1 lidocaine and 100 nmol·L-1 dofetilide (LID + DOF) or
750 nmol·L-1 verapamil and 100 nmol·L-1 dofetilide (VER + DOF) in
the second set of experiments. Each group contained eight hearts.
Values are percentage incidences of arrhythmias. *P < 0.05 versus
DMSO, #P < 0.05 versus H2O, †P < 0.05 versus DOF2. DMSO,
dimethyl sulphoxide; ECG, electrocardiogram.
NCX inhibition and torsades de pointes
926 AS Farkas et al
British Journal of Pharmacology (2009) 156 920–932
Oliva, 2006). DADs can be produced by Ca2+ wave-activated,
inward currents resulted from the activation of the NCX
(Sipido et al., 2006). Accordingly, NCX inhibition antago-
nized DAD-dependent, digitalis-induced arrhythmias in
several in vitro and in vivo experimental models (Watano et al.,
1999; Nagy et al., 2004; Nagasawa et al., 2005; Shpak et al.,
2006).
Although many results suggest a role of NCX in the genesis
of drug-induced TdP, selective inhibition of the NCX did not
prevent dofetilide-induced TdP in isolated rabbit hearts in the
present study. The initiating mechanism of TdP in isolated,
Langendorff-perfused, AV-blocked, non-paced rabbit hearts is
unknown. However, in an earlier study with AV-blocked
rabbit hearts, an EAD was associated with the initiating beat
of d-sotalol-induced TdP (Zabel et al., 1997). If EADs (or
DADs) serve as the trigger for TdP in the rabbit hearts in the
present study, then the genesis of these triggered activities was
not related to the activity of the NCX. Our results are in
agreement with earlier findings showing that selective inhi-
bition of the NCX with SEA0400 did not affect the inward
rectifier potassium current (Ik1) blocker Ba2+-induced triggered
activity and DAD in guinea pig myocytes (Homma et al.,
2006) and SEA0400 also did not suppress aconitine-induced,
EAD- and DAD-dependent arrhythmias in an in vivo guinea
pig model of type-3 long QT syndrome (Amran et al., 2004).
Alternatively, it is possible that the trigger of TdP did not
originate from EADs or DADs in the present study. It is pos-
sible that any beats of the irregular idioventricular escape
rhythm that occurred in the vulnerable period of the
dofetilide-produced re-entry circuits could serve for a trigger
for TdP. These beats do not depend on NCX activity, which
may explain the ineffectiveness of NCX inhibition.
NCX does not contribute to the maintenance of TdP
It is widely accepted that the mechanism of maintenance
(substrate) of TdP arrhythmia involves re-entry circuits pro-
duced by an increase in spatial dispersion of the repolariza-
tion of the ventricular wall. The transmural dispersion has
been identified as the principal arrhythmogenic substrate in
both acquired and congenital long QT syndrome (LQTS) (Ant-
zelevitch and Oliva, 2006). In dogs and humans, the trans-
mural dispersion of repolarization is the consequence of
longer APD in M cells, compared with those in epicardial and
endocardial cells (Antzelevitch and Oliva, 2006). Zygmunt
et al. (2000) showed that the longer APD is due to the smaller
Figure 4 The heart rate-corrected QT (QTc) intervals (A and B) and the RR intervals (C and D) during the pretreatment and the treatment
periods in AV-ablated isolated rabbit hearts in the first set of experiments. Values are mean  SEM. *P < 0.05 versus DMSO; #P < 0.05 versus
H2O; †P < 0.05 versus DOF1. For further details, see Figure 3. DMSO, dimethyl sulphoxide.
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slow component of the delayed rectifier potassium current
(IKs) and larger late INa and NCX currents in the healthy canine
ventricle. The IKr inhibitor d,l-sotalol increased transmural
dispersion of repolarization and induced TdP in isolated,
Langendorff-perfused, AV-blocked rabbit hearts (Eckardt et al.,
2002). Further, verapamil prevented veratridine-induced TdP
via reduction of left ventricular transmural dispersion of repo-
larization (and suppression of EADs) in isolated, Langendorff-
perfused, AV-blocked rabbit hearts (Milberg et al., 2005).
These earlier observations suggest that transmural dispersion
of repolarization may also play a role in the maintenance of
TdP in AV-ablated rabbit hearts. Although NCX activity con-
tributes to the generation of transmural dispersion of repolar-
ization in the healthy dog heart (Zygmunt et al., 2000), our
results indicate that NCX activity does not increase the trans-
mural dispersion of repolarization and, therefore, does not
contribute to the maintenance mechanism of TdP in the
rabbit heart.
The effect of SEA0400 on the duration of repolarization
SEA0400 is a highly selective and effective inhibitor of the
NCX at a concentration of 1.0 mmol·L-1 (Matsuda et al., 2001;
Takahashi et al., 2003; Farkas et al., 2008). To date, no experi-
mental data have been reported on an appreciable effect of
this concentration of SEA0400 on the repolarization. Our
study did not involve a separate group of hearts with SEA0400
perfusion alone during the 20 min ‘pretreatment’ and the
subsequent 30 min ‘treatment’ period; thus, we cannot
exclude the possibility that the drug affects repolarization and
causes arrhythmias after prolonged exposure. However,
30 min perfusion with SEA0400 at a concentration of
1.0 mmol·L-1, which is the same concentration we used in the
present study, did not affect ECG parameters and did not
induce any arrhythmias in isolated rat and rabbit hearts in a
recent study from our laboratory (Farkas et al., 2008). Simi-
larly, 20 min SEA0400 pretreatment did not affect the control
QTc in the present study. In contrast, when the subsequent
treatment period started and the IKr inhibitor dofetilide was
added to the SEA0400 perfusion, repolarization prolonged
quickly and markedly in 5 min, and a significantly longer QTc
was measured than that in the group of hearts perfused with
dofetilide on its own. These observations suggest that
SEA0400 prolongs repolarization only when the repolariza-
tion reserve is markedly reduced by the co-administration of
another drug. Nevertheless, further investigations would help
Table 2 The beat-to-beat variability of the QT interval in isolated, Langendorff-perfused, AV-blocked rabbit hearts
n SD RMS RMSSD PNN8 Instability LTV STV
First set of experiments
H2O
Baseline 8 11  2 225  13 15  2 25  4 12  2 8  1 8  1
Pretreat 8 11  2 254  6 11  2 23  4 14  3 10  3 6  1
Treat 8 14  2 253  19 18  3 25  3 14  2* 11  2 9  2
DMSO
Baseline 8 17  4 233  12 24  7 30  4 20  5 11  3 13  4
Pretreat 8 18  4 251  13 23  5 31  3 20  3 14  3 12  2
Treat 8 22  3 267  15 30  6 38  3# 30  5# 16  2 17  4
DOF1
Baseline 8 14  2 217  9 16  2 29  3 17  3 11  2 9  1
Pretreat 8 16  5 226  6 20  5 26  5 19  4 13  3 10  2
Treat 8 73  15*# 389  55*# 87  17*# 41  3# 65  19# 63  16*# 40  8*#
SEA + DOF
Baseline 8 14  4 225  12 18  6 27  3 21  7 12  3 10  4
Pretreat 8 14  2 258  20 18  3 27  4 17  3 12  2 9  2
Treat 8 101  27*# 589  45*#† 91  25*# 40  3# 145  53*# 102  32*# 42  12*#
Second set of experiments
DOF2
Baseline 8 15  3 242  10 23  5 30  4 21  5 9  1 13  4
Pretreat 8 12  2 245  9 17  4 27  3 14  3 9  2 9  2
Treat 8 42  12 308  17 49  14 39  4 60  16 35  12 27  8
DOF + LID
Baseline 8 18  8 228  15 26  18 24  4 11  2 10  3 9  2
Pretreat 8 21  12 256  14 31  18 25  4 17  5 17  10 15  9
Treat 8 31  9 459  97‡ 47  14 38  5 45  15 20  6 27  8
DOF + VER
Baseline 8 12  2 225  8 16  3 27  5 12  2 8  1 9  2
Pretreat 8 19  6 293  17 22  5 29  2 17  3 13  3 10  1
Treat 8 101  36 588  115‡ 135  61 38  6 161  62 72  23 78  39
The beat-to-beat QT variability parameters in the first set of experiments and in the second set of experiments.
Values shown are mean  SEM. *P < 0.05 versus DMSO; #P < 0.05 versus H2O; †P < 0.05 versus DOF1; ‡P < 0.05 versus DOF2. For further details, see Figures 2
and 3.
AV, atrioventricular; DMSO, dimethyl sulphoxide; pretreat, pretreatment period; treat, treatment period; group size is indicated by n. SD, the standard deviation
of the measured 40 consecutive QT intervals (ms); RMS, the root mean square of the measured 40 consecutive QT intervals (ms); RMSSD, the root mean square
of the successive difference of the QT intervals (ms); PNN8, percentage of QT intervals differing from the preceding one by more than 8 ms (%); instability, QT
instability (ms); LTV, long-term variability of the QT intervals (ms); STV, short-term variability of the QT intervals (ms); DOF, dofetilide; LID, lidocaine; SEA, SEA 0400;
VER, verapamil.
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to characterize the effect of SEA0400 on repolarization after
long exposure.
In the present study, SEA0400 pretreatment did not affect
the control QTc, but the drug prolonged significantly the
QTc in the presence of the IKr inhibitor dofetilide. This
observation may have two possible explanations. (i) NCX
contributes a small outward current at the end of the action
potential plateau that, in the absence of repolarization
reserve (i.e. in dofetilide) delays repolarization; and/or (ii)
SEA0400 is non-selective for NCX and affects other repolar-
izing currents.
With regard to the former explanation, Sher et al. (2007)
have reported computer simulations in which NCX may gen-
erate an outward current at the end of the action potential
plateau. Blocking this current, in the absence of repolarization
reserve, may thus prolong APD. However, other simulations
by Bers et al. (Bers, 2001) have suggested that, apart from a
very brief period at the start of the action potential, NCX
remains inward throughout the cardiac cycle. The second
possibility is that SEA0400 is not selective for NCX and blocks
other repolarizing currents. However, in guinea pig myocytes,
SEA0400 at a concentration of 1.0 mmol·L-1 caused only 4%
and 2% inhibition on Ik (at 37°C) and Ik1 currents respectively
(Tanaka et al., 2002). SEA0400 may also inhibit smaller repo-
larizing currents, for example IKs, but this has never been
examined. Either explanation requires that the potential
repolarization-influencing effect of SEA0400 was minimal
when administered alone, but was revealed when the repolar-
ization reserve was reduced by the potent IKr blocker, dofetil-
ide. Our findings on the effect of SEA0400 on the QTc interval
propose that inhibition of the NCX by SEA0400 may exacer-
bate the proarrhythmic effect of dofetilide. However, this
requires further investigation in a setting where control inci-
dence of dofetilide-induced TdP is low.
Neither the duration of the QT interval nor the beat-to-beat
variability of the QT interval correlated with the occurrence
of TdP
A substantial amount of experimental and clinical data
suggest that QT prolongation alone is an unreliable predictor
of drug-induced TdP (Thomsen et al., 2006). In our study,
verapamil exaggerated the dofetilide-induced QTc prolonga-
tion while the drug prevented TdP. Likewise, lidocaine
decreased significantly the incidence of TdP but did so
without affecting the QTc interval. These results corroborate
earlier reports showing that QT prolongation did not correlate
with the proarrhythmic liability of repolarization-prolonging
drugs in isolated, AV-blocked rabbit hearts (Eckardt et al.,
2002; Milberg et al., 2002).
Table 3 The beat-to-beat variability of the RR interval in isolated, Langendorff-perfused, AV-blocked rabbit hearts
n SD RMS RMSSD Instability LTV STV
First set of experiments
H2O
Baseline 8 53  20 447  65 92  37 71  35 21  9 55  24
Pretreat 8 36  14 681  147 44  19 45  21 26  11 24  12
Treat 8 174  145 783  197 191  162 44  21 105  80 48  32
DMSO
Baseline 8 63  35 482  67 81  56 116  68 37  30 50  38
Pretreat 8 385  211 944  258 492  254 208  66 260  157 168  69
Treat 8 135  57 680  174 143  41 223  91 119  65 77  23
DOF1
Baseline 8 42  20 443  24 72  38 57  36 17  9 44  25
Pretreat 8 117  93 566  88 171  140 51  35 52  37 58  46
Treat 8 398  216 1057  318 535  313 166  90 231  94 149  62
SEA + DOF
Baseline 8 151  48 575  29 251  91 281  85 68  30 151  56
Pretreat 8 52  26 729  137 34  18 48  21 45  21 14  7
Treat 8 429  109*# 1251  81 534  152 350  82#† 341  90 244  70
Second set of experiments
DOF2
Baseline 8 141  54 541  38 262  99 232  87 39  34 165  62
Pretreat 8 75  43 590  63 113  79 102  83 37  18 65  53
Treat 8 183  49 706  75 267  76 202  72 120  33 125  34
DOF + LID
Baseline 8 108  40 574  66 180  81 169  82 36  11 112  57
Pretreat 8 155  107 892  122 268  208 279  202 37  30 171  140
Treat 8 649  321 1660  716 1043  505 588  375 333  175 519  267
DOF + VER
Baseline 8 89  54 530  61 141  85 112  54 56  44 77  42
Pretreat 8 33  16 970  182 36  17 35  15 27  13 12  5
Treat 8 854  3 1920  342‡ 1301  540 11169  495 540  211 709  304
The beat-to-beat RR variability parameters in the first set of experiments and in the second set of experiments. Group size is indicated by n.
Values shown are mean  SEM. *P < 0.05 versus DMSO; #P < 0.05 versus H2O; †P < 0.05 versus DOF1; ‡P < 0.05 versus DOF2. For further details, see Figures 2
and 3 and Table 2.
AV, atrioventricular; DMSO, dimethyl sulphoxide; SD, the standard deviation of the measured 40 consecutive RR intervals (ms); RMS, the root mean square of the
measured 40 consecutive RR intervals (ms). RMSSD, the root mean square of the successive difference of the RR intervals (ms); Instability, QT instability (ms); LTV,
long-term variability of the QT intervals (ms); STV, short-term variability of the QT intervals (ms). DOF, dofetilide: LID, lidocaine; SEA, SEA 0400; VER, verapamil.
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The temporal dispersion of repolarization defined as the
beat-to-beat variability of the monophasic APD has been
shown to predict the proarrhythmic activity of repolarization-
prolonging drugs in isolated rabbit hearts (Hondeghem et al.,
2001) and in chronic AV-blocked dogs in vivo (Thomsen et al.,
2004). In accordance with this, Lengyel et al. (2007) found
that the beat-to-beat variability of the QT interval predicted
the occurrence of drug-induced TdP in anaesthetized rabbits.
In contrast, the beat-to-beat variability of the QT interval
failed to predict repolarization-prolonging-drug-induced TdP
in two recent investigations with adrenergically stimulated,
anaesthetized rabbits (Michael et al., 2007; Vincze et al.,
2008). Thus, the predictive power of an increase in the beat-
to-beat variability of the QT interval is debatable. In our
isolated heart study, 100 nmol·L-1 dofetilide perfusion
increased each QT variability parameter, and the drug
induced TdP reproducibly in nearly all hearts. On the other
hand, neither verapamil nor lidocaine decreased any of the
QT variability parameters; nevertheless, they successfully
block the development of TdP. Thus, the predictive value of
an increase in the beat-to-beat variability of the QT interval in
isolated, AV-ablated, non-paced rabbit hearts is questionable.
Further investigation is needed to clarify whether it is because
an increase in the beat-to-beat variability of the action poten-
tial is not a contributor to TdP or rather it is because an
increase in the beat-to-beat variability of the QT interval is
only one out of several contributing factors that need to be
present at the same time to allow generation of TdP in the
model.
AV block-induced electrical instability
In our study, acute AV block was applied in order to slow
down the ventricular heart rate as bradycardia has been
reported to increase the proarrhythmic activity of IKr blockers
in isolated rabbit hearts (Eckardt et al., 1998). Surprisingly, AV
block resulted in a chaotic idioventricular rhythm in all hearts
during control conditions. This chaotic idioventricular
rhythm is characterized by an elevated beat-to-beat variability
of the RR and QT intervals in our study. Similar electrical
instability was reported in isolated mouse hearts after AV
ablation, and the level of instability (i.e. the incidence of
baseline arrhythmias after AV block) inversely correlated with
the K+ concentration of the perfusion solution (Fabritz et al.,
2003). Accordingly, perfusion with 3 mmol·L-1 K+ induced
afterdepolarizations in nearly all mouse hearts and evoked
Figure 5 The heart rate-corrected QT (QTc) intervals (A and B) and the RR intervals (C and D) during the pretreatment and the treatment
periods in AV-ablated isolated rabbit hearts in the second set of experiments. Values are mean  SEM. *P < 0.05 versus DOF2. For further details,
see Figure 3. AV, atrioventricular.
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polymorphic ventricular tachycardia in one mouse heart
during control conditions, after AV ablation (Fabritz et al.,
2003). This may explain why the evaluation of our experi-
ments with 3 mmol·L-1 K+ in the perfusion solution found a
run of ‘TdP’ in a heart in the DMSO control group. Further,
the baseline electrical instability in the AV-blocked rabbit
hearts perfused with 3 mmol·L-1 K+ in the present study might
contribute to the high sensitivity of these hearts to the proar-
rhythmic activity of dofetilide.
The antiarrhythmic effect of verapamil and
lidocaine against TdP
The ICaL channel blocker verapamil significantly prolonged
the QT interval in the presence of dofetilde and prevented the
development of TdP. Verapamil (which has never been
reported to cause TdP and indeed has been proposed as a
therapy for long QT-related arrhythmias) inhibited IKr in the
same concentration range as quinidine and amiodarone (Yang
et al., 2001). This may explain why the drug prolonged
further the QT interval, when the repolarization reserve was
very small as a result of dofetilide perfusion. Verapamil also
prolonged the mean RR interval, that is, reduced the number
of idioventricular beats mostly when it was co-perfused with
dofetilide. This effect might reduce the number of trigger
beats for the initiation of TdP irrespective of the fact that the
trigger was either the idioventricular beat itself or the corre-
sponding afterdepolarization. As lidocaine tended to have the
same effect on the ventricular rate, this may also explain its
antiarrhythmic effect in our investigations. Shimizu et al.
(1995) reported that verapamil suppressed spontaneous or
adrenaline-induced EADs and TdP in patients with congenital
LQTS. Milberg et al. (2005) found that the same concentration
of verapamil we used (750 nmol·L-1) prevented TdP via the
reduction of EAD and ventricular transmural dispersion of
repolarization in an isolated rabbit heart model of the
acquired LQT3 syndrome. Likewise, lidocaine suppressed the
IKr blocker almokalant-induced dispersion of repolarization
and the development of EADs in rabbit Purkinje fibres in vitro
(Abrahamsson et al., 1996). Thus, the antiarrhythmic effect of
verapamil and lidocaine in our experiments may also be
related their direct effect on the development of EAD and/or
dispersion of the repolarization.
Conclusions
Na+/Ca2+ exchanger neither contributed to the initiation nor
assisted the maintenance of dofetilide-induced TdP in our in
vitro experimental model, in which inhibition of the INa and
ICaL currents successfully antagonized the genesis of this
arrhythmia. Neither QTc prolongation nor an increase in the
beat-to-beat variability of the QT interval is a sufficient pre-
requisite of TdP genesis in this model. AV ablation resulted in
a chaotic idioventricular rhythm, which might make the
hearts more sensitive to the proarrhythmic activity of dofetil-
ide in the applied isolated rabbit heart model.
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